During this session, expert panel members will provide an overview of the vast array of solutions that AI-enabled signal processing, brain computer interfaces (BCIs) and Neuro-technologies can potentially bring to improve the quality of life of Persons with Disabilities. User testimonies and examples of existing applications will be shared as well as current research that may lead to potential breakthroughs in key areas such as BCI enabled communications for persons with aphasia or allowing control and sensory feedback for individuals with artificial limbs. Looking forward, the panel will discuss how the perspective and requirements of persons with disabilities may be best factored in regulatory approval processes and in addressing the complex ethical issues around invasive and non-invasive BCIs and the manipulation of user data.
Session Chair: Theresa Vaughan, Research Scientist, NCAN; G3ict/NeuroAbilities Program Advisory Council Chair
Panelists:
- Ramses Alcaide, Ph.D., CEO, Neurable
- Sandy Hanebrink, Executive Director, Touch the Future, Inc.; G3ict/NeuroAbilities Program Advisory Council Member
- Mary Keszler, Medical Officer, U.S. Food and Drug Administration
- Naeem Komeilipoor, Founder and CEO, AAVAA